Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07396441Phase 4Recruiting
Phase 4, randomised, open-label trial in Juvenile Open Angle Glaucoma (JOAG) and dry eye disease (DED) (2 arms), sponsored by Universiti Sains Malaysia. Primary endpoint: Serum Interleukin-6 Level at 90 days. Started Jan 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07396441.